Paritosh Prashar
Co-founder
Boltzmann Labs
This company provides an AI-powered research platform that automates molecular design, property prediction, and lab execution for drug discovery. Their multi-agent system optimizes R&D workflows, enabling users to rapidly identify and refine small molecule candidates with desired safety and efficacy profiles. The platform integrates generative chemistry and predictive modeling to accelerate the transition from hypothesis to synthesis-ready compounds.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
- Enterprise Software
Updated 6 months ago
Funding
Raised to date
$200KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an AI-powered drug discovery platform that utilizes data-driven methodologies to enhance traditional drug design processes. By providing scientists in the pharmaceutical industry with user-friendly AI tools, the platform accelerates research timelines and facilitates the development of novel therapeutics, ultimately aiming to reduce the burden of diseases on patients.